Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 100,902 | 125,466 | 104,016 | 64,022 | 19,995 |
| Operating Income | -100,902 | -125,466 | -104,016 | -64,022 | -19,995 |
| Other Income | 3,962 | 7,794 | 8,377 | 9,169 | 40 |
| Pre-tax Income | -96,940 | -117,672 | -95,639 | -54,853 | -19,955 |
| Net Income Continuous | -96,940 | -117,672 | -95,639 | -54,853 | -19,955 |
| Net Income | $-96,940 | $-117,672 | $-95,639 | $-54,853 | $-19,955 |
| EPS Basic Total Ops | -25.20 | -30.90 | -25.30 | -14.90 | -16.70 |
| EPS Basic Continuous Ops | -25.19 | -30.95 | -25.35 | -14.86 | -16.68 |
| EPS Diluted Total Ops | -25.20 | -30.90 | -25.30 | -14.90 | -16.70 |
| EPS Diluted Continuous Ops | -25.19 | -30.95 | -25.35 | -14.86 | -16.68 |
| EPS Diluted Before Non-Recurring Items | -25.20 | -30.90 | -25.30 | -14.90 | -16.70 |
| EBITDA(a) | $-100,447 | $-125,911 | $-103,593 | $-63,050 | $-19,742 |